Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 3/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 7/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | EDNRA | P25101 | 2/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13444565 | 1.00 | KDM4E (0.43) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL13444522 | 1.00 | KDM4E (0.43) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL13444306 | 0.99 | KDM4E (0.42) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL13444412 | 0.99 | KDM4E (0.42) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL13444514 | 0.99 | KDM4E (0.42) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL11981034 | 0.99 | L3MBTL1 (0.44) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL32672520 | 0.99 | L3MBTL1 (0.44) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL14212263 | 0.99 | L3MBTL1 (0.44) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL13444551 | 0.98 | KDM4E (0.41) | KDM4EATML3MBTL1HDAC4PGR | |
| SCHEMBL15446130 | 0.98 | KDM4E (0.43) | KDM4EATML3MBTL1HDAC4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49237-E1 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2022-10-04 | — | — | US | disclosed |
| US-10707434-B2 | Organic electroluminescence element, and material for organic electroluminescence element | IDEMITSU KOSAN CO., LTD. (JP) | 2020-07-07 | — | — | US | disclosed |
| US-20190019972-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2019-01-17 | — | — | US | disclosed |
| US-9882140-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-9882140-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-20160268517-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160268517-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20160155942-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-02 | — | — | US | disclosed |
| US-20160155942-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-02 | — | — | US | disclosed |
| US-20150249219-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
| US-20150249219-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
| US-20140306207-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-16 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140048784-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
| US-20140048784-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190019972-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | LEF1, L1CAM, AGO2 | KDM4E 3248/4885ATM 2324/4885L3MBTL1 1678/4885 |
| US-20160268517-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | L1CAM, CCNT1, CCNA1 | KDM4E 2191/4885ATM 4082/4885L3MBTL1 30/4885 |
| US-10707434-B2 | Organic electroluminescence element, and material for organic electroluminescence element | LEF1, L1CAM, AGO2 | KDM4E 3248/4885ATM 2324/4885L3MBTL1 1678/4885 |
| US-20150249219-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | L1CAM, CCNT1, CCNA1 | KDM4E 2205/4885ATM 4082/4885L3MBTL1 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.